ArticleEMBO reports2019
HRAS-driven cancer cells are vulnerable to TRPML1 inhibition.
Jewon Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
53 papers cite it
this papercites it
ArticleEMBO reports2019
Jewon Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.